Monday, October 5

    ACCESS Newswire

    / AELF announced today that it has welcomed Alexander “AJ” Issenman to the company as Director of Capital Markets. Issenman joins AELF from Seabury Capital, where he served as a Director at Seabury Capital Management focusing on merchant banking and

    / HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide variety of patients suffering from hard-to-treat solid tumors or hematological malignancies, today announced the acceptance of poster presentation at

    / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its Business Update for the fourth quarter of Fiscal Year 2023 ended June 30, 2023.